Alfonso Bellacosa Selected Research

Alfonso Bellacosa Research Topics

Disease

21	Neoplasms (Cancer) 01/2022 - 10/2002
6	Melanoma (Melanoma, Malignant) 06/2022 - 08/2009
5	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 06/2007
4	Genomic Instability 01/2023 - 08/2006
3	Tuberous Sclerosis (Bourneville's Disease) 03/2017 - 12/2004
2	Adenoma (Adenomas) 01/2023 - 10/2017
2	Neoplasm Metastasis (Metastasis) 08/2015 - 05/2003
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 03/2011 - 09/2008
2	Carcinoma (Carcinomatosis) 01/2010 - 06/2007
2	Breast Neoplasms (Breast Cancer) 01/2010 - 10/2002
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2008 - 05/2003
2	Colonic Neoplasms (Colon Cancer) 02/2008 - 06/2007
1	Endometrial Neoplasms (Endometrial Cancer) 10/2022
1	Medulloblastoma 01/2020
1	Sciatic Neuropathy (Lesion of Sciatic Nerve) 04/2017
1	Ganglion Cysts (Ganglion) 04/2017
1	Peripheral Nerve Injuries 04/2017
1	Ovarian Neoplasms (Ovarian Cancer) 01/2010
1	Carcinogenesis 01/2010
1	Lung Neoplasms (Lung Cancer) 02/2008
1	Leukemia 01/2003
1	Hypertrophy 09/2002

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 10/2019 - 01/2004
5	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2015
4	Thymine DNA GlycosylaseIBA 06/2022 - 04/2017
4	RNA (Ribonucleic Acid)IBA 01/2020 - 06/2003
3	Phosphotransferases (Kinase)IBA 01/2022 - 03/2004
3	trans-sodium crocetinate (crocetin)IBA 03/2017 - 12/2004
3	Cadherins (E-Cadherin)IBA 08/2015 - 05/2003
3	ProteomeIBA 03/2011 - 06/2007
2	CateninsIBA 10/2022 - 08/2015
2	Oncogene Proteins (Oncogene Protein)IBA 01/2022 - 01/2005
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 08/2009
2	Messenger RNA (mRNA)IBA 08/2015 - 01/2010
2	Biomarkers (Surrogate Marker)IBA 01/2010 - 09/2008
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2005 - 01/2003
1	Interferon-gamma (Interferon, gamma)IBA 01/2023
1	InterferonsIBA 01/2023
1	GTP Phosphohydrolases (GTPases)IBA 01/2022
1	Proteolysis Targeting ChimeraIBA 01/2022
1	Lapatinib (GW572016)FDA Link 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	5-Methylcytosine (5 Methylcytosine)IBA 03/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Histone-Lysine N-MethyltransferaseIBA 01/2020
1	A-Form DNA (A-DNA)IBA 10/2019
1	UracilIBA 10/2019
1	ThymineIBA 10/2019
1	5-carboxylcytosineIBA 01/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018
1	Retinaldehyde (Retinal)IBA 04/2017
1	5-hydroxymethylcytosineIBA 04/2017
1	DNA Glycosylases (DNA Glycosylase)IBA 12/2015
1	Poly AIBA 12/2015
1	Caveolin 1IBA 08/2015
1	Small Interfering RNA (siRNA)IBA 08/2010
1	Amyloid (Amyloid Fibrils)IBA 01/2010
1	mirdametinibIBA 08/2009
1	hydrogen sulfite (bisulfite)IBA 01/2009
1	Histones (Histone)IBA 02/2008
1	bacteriophage T7 RNA polymerase (T7 RNA polymerase)IBA 12/2004
1	Protein Kinases (Protein Kinase)IBA 05/2003
1	Complement System Proteins (Complement)IBA 05/2003
1	beta CateninIBA 05/2003
1	Desmoplakins (Desmoplakin)IBA 05/2003
1	VimentinIBA 05/2003
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2003
1	Cyclin-Dependent Kinase Inhibitor p27IBA 10/2002
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 10/2002
1	Mitogen-Activated Protein KinasesIBA 09/2002
1	Glycogen Synthase (Synthase I)IBA 09/2002

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2003
1	Ovariectomy (Oophorectomy) 10/2017
1	Chemoprevention 01/2010
1	Drug Therapy (Chemotherapy) 06/2003